IPUMS PMA: vars by group: famp

Person

FAMILY PLANNING Description	NUTRITION Description
CLIENT EXIT INTERVIEW Description	COVID-19 Description

Service Delivery Point

FAMILY PLANNING

Description

NUTRITION

Description

Infant

MATERNAL AND NEWBORN HEALTH

Description

Use this option if persons are the unit of analysis. Each record represents a household member, including resident women of childbearing age. Variables shown are based on either the household or female questionnaire.

Childbearing age is typically defined as ages 15-49.

Use this option if service delivery providers are the unit of analysis. Each record represents one facility, drawn from the same enumeration areas from which households were sampled.

Service delivery points include hospitals, health centers, clinics, pharmacies, and other facilities that might provide family planning services or products. The questionnaire was completed by a competent staff person at the facility.

Use this option if infants or women who have just given birth are the unit of analysis. Each record represents one infant.

These data are from a Maternal and Newborn Health survey, in which pregnant women are interviewed several times before and after delivery.

Use this option if persons are the unit of analysis. Each record represents a household member, including resident women between age 10 and 49, and young children. Variables shown are based on either the household or female questionnaire.

Use this option if service delivery providers are the unit of analysis. Each record represents one facility, drawn from the same enumeration areas from which households were sampled for the Nutrition surveys.

Service delivery points include hospitals, health centers, clinics, pharmacies, and other facilities that might provide nutrition programming or services. The questionnaire was completed by a competent staff person at the facility.

Use this option if women of childbearing age are the unit of analysis. Each record represents one woman who was interviewed as they were leaving a medical appointment at a surveyed service delivery point.

Use this option if women of childbearing age are the unit of analysis. Each record represents one woman who completed a phone interview about COVID-19.

An "X" indicates the variable is available in that dataset.

Add to cart	Variable	Variable Label	Type	burkf 2014	burkf 2015	burkf 2016a	burkf 2016b	burkf 2017	burkf 2018	burkf 2020	burkf 2021	burkf 2022	condr 2013	condr 2014	condr 2015a	condr 2015b	condr 2015c	condr 2016a	condr 2016b	condr 2017a	condr 2017b	condr 2018a	condr 2018b	condr 2019a	condr 2019b	condr 2020	condr 2020	condr 2021	Variable	condr 2021	cotedi 2017	cotedi 2018	cotedi 2020	cotedi 2020b	cotedi 2021	cotedi 2022	ethio 2014a	ethio 2014b	ethio 2015	ethio 2016	ethio 2017	ethio 2018	ethio 2019	ethio 2020	ethio 2021	ghana 2013	ghana 2014a	ghana 2014b	ghana 2015	ghana 2016	ghana 2017	india 2016	india 2017a	india 2017b	Variable	india 2018	india 2020	india 2021	india 2022	indon 2015	indon 2016	kenya 2014a	kenya 2014b	kenya 2015a	kenya 2015b	kenya 2016	kenya 2017	kenya 2018	kenya 2019	kenya 2020	kenya 2021	niger 2015	niger 2016a	niger 2016b	niger 2017	niger 2018	niger 2020	niger 2022	niger 2023	nigera 2014a	Variable	nigera 2014b	nigera 2015a	nigera 2015b	nigera 2016	nigera 2017a	nigera 2017b	nigera 2018	nigera 2019a	nigera 2019b	nigera 2019c	nigera 2020a	nigera 2020b	nigera 2021a	nigera 2021b	ugand 2014	ugand 2015a	ugand 2015b	ugand 2016	ugand 2017	ugand 2018	ugand 2019	ugand 2020	ugand 2021	ugand 2022
Side Effects (experienced) Variables [top]
Add to cart	Variable	Variable Label	Type	BF 14	BF 15	BF 16a	BF 16b	BF 17	BF 18	BF 20	BF 21	BF 22	CD 13	CD 14	CD 15a	CD 15b	CD 15c	CD 16a	CD 16b	CD 17a	CD 17b	CD 18a	CD 18b	CD 19a	CD 19b	CD 20	CD 20	CD 21	Variable	CD 21	CI 17	CI 18	CI 20	CI 20b	CI 21	CI 22	ET 14a	ET 14b	ET 15	ET 16	ET 17	ET 18	ET 19	ET 20	ET 21	GH 13	GH 14a	GH 14b	GH 15	GH 16	GH 17	IN 16	IN 17a	IN 17b	Variable	IN 18	IN 20	IN 21	IN 22	ID 15	ID 16	KE 14a	KE 14b	KE 15a	KE 15b	KE 16	KE 17	KE 18	KE 19	KE 20	KE 21	NE 15	NE 16a	NE 16b	NE 17	NE 18	NE 20	NE 22	NE 23	NG 14a	Variable	NG 14b	NG 15a	NG 15b	NG 16	NG 17a	NG 17b	NG 18	NG 19a	NG 19b	NG 19c	NG 20a	NG 20b	NG 21a	NG 21b	UG 14	UG 15a	UG 15b	UG 16	UG 17	UG 18	UG 19	UG 20	UG 21	UG 22
	FPSEOTH	Side effect experienced: other	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEOTH	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEOTH	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEOTH	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEREC	Experienced side effects recently	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEREC	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEREC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEREC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.
	FPSERECUTCRAMP	Side effect experienced recently: uterine cramping/lower abdominal pain	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECUTCRAMP	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECUTCRAMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECUTCRAMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSERECFACE	Side effect experienced recently: facial spotting	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECFACE	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECFACE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECFACE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSERECBACK	Side effect experienced recently: backache	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECBACK	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECBACK	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECBACK	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSERECDIARR	Side effect experienced recently: diarrhea	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECDIARR	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECDIARR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECDIARR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSERECWTGAIN	Side effect experienced recently: gained weight	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECWTGAIN	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECWTGAIN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECWTGAIN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSERECHEADACHE	Side effect experienced recently: headaches	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECHEADACHE	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECHEADACHE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECHEADACHE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSERECINFECT	Side effect experienced recently: got infection	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECINFECT	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECINFECT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECINFECT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSERECPAIN	Side effect experienced recently: pain at insertion site	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECPAIN	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECPAIN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECPAIN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSERECIRREG	Side effect experienced recently: irregular bleeding/spotting	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECIRREG	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECIRREG	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECIRREG	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSERECBLEEDLESS	Side effect experienced recently: less or no bleeding	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECBLEEDLESS	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECBLEEDLESS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECBLEEDLESS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSERECPLEAS	Side effect experienced recently: decreased sexual pleasure	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECPLEAS	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECPLEAS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECPLEAS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSERECWTLOSS	Side effect experienced recently: lost weight	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECWTLOSS	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECWTLOSS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECWTLOSS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSERECLIBIDO	Side effect experienced recently: lowered sex drive	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECLIBIDO	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECLIBIDO	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECLIBIDO	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSERECCRAMP	Side effect experienced recently: increased menstrual cramping	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECCRAMP	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECCRAMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECCRAMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSERECMOOD	Side effect experienced recently: mood swings	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECMOOD	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECMOOD	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECMOOD	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSERECBLEEDMORE	Side effect experienced recently: heavier bleeding	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECBLEEDMORE	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECBLEEDMORE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECBLEEDMORE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSERECNAUSEA	Side effect experienced recently: nausea/vomiting	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECNAUSEA	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECNAUSEA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECNAUSEA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSERECOTH	Side effect experienced recently: other	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECOTH	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECOTH	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECOTH	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
Add to cart	Variable	Variable Label	Type	burkf 2014	burkf 2015	burkf 2016a	burkf 2016b	burkf 2017	burkf 2018	burkf 2020	burkf 2021	burkf 2022	condr 2013	condr 2014	condr 2015a	condr 2015b	condr 2015c	condr 2016a	condr 2016b	condr 2017a	condr 2017b	condr 2018a	condr 2018b	condr 2019a	condr 2019b	condr 2020	condr 2020	condr 2021	Variable	condr 2021	cotedi 2017	cotedi 2018	cotedi 2020	cotedi 2020b	cotedi 2021	cotedi 2022	ethio 2014a	ethio 2014b	ethio 2015	ethio 2016	ethio 2017	ethio 2018	ethio 2019	ethio 2020	ethio 2021	ghana 2013	ghana 2014a	ghana 2014b	ghana 2015	ghana 2016	ghana 2017	india 2016	india 2017a	india 2017b	Variable	india 2018	india 2020	india 2021	india 2022	indon 2015	indon 2016	kenya 2014a	kenya 2014b	kenya 2015a	kenya 2015b	kenya 2016	kenya 2017	kenya 2018	kenya 2019	kenya 2020	kenya 2021	niger 2015	niger 2016a	niger 2016b	niger 2017	niger 2018	niger 2020	niger 2022	niger 2023	nigera 2014a	Variable	nigera 2014b	nigera 2015a	nigera 2015b	nigera 2016	nigera 2017a	nigera 2017b	nigera 2018	nigera 2019a	nigera 2019b	nigera 2019c	nigera 2020a	nigera 2020b	nigera 2021a	nigera 2021b	ugand 2014	ugand 2015a	ugand 2015b	ugand 2016	ugand 2017	ugand 2018	ugand 2019	ugand 2020	ugand 2021	ugand 2022
Add to cart	Variable	Variable Label	Type	BF 14	BF 15	BF 16a	BF 16b	BF 17	BF 18	BF 20	BF 21	BF 22	CD 13	CD 14	CD 15a	CD 15b	CD 15c	CD 16a	CD 16b	CD 17a	CD 17b	CD 18a	CD 18b	CD 19a	CD 19b	CD 20	CD 20	CD 21	Variable	CD 21	CI 17	CI 18	CI 20	CI 20b	CI 21	CI 22	ET 14a	ET 14b	ET 15	ET 16	ET 17	ET 18	ET 19	ET 20	ET 21	GH 13	GH 14a	GH 14b	GH 15	GH 16	GH 17	IN 16	IN 17a	IN 17b	Variable	IN 18	IN 20	IN 21	IN 22	ID 15	ID 16	KE 14a	KE 14b	KE 15a	KE 15b	KE 16	KE 17	KE 18	KE 19	KE 20	KE 21	NE 15	NE 16a	NE 16b	NE 17	NE 18	NE 20	NE 22	NE 23	NG 14a	Variable	NG 14b	NG 15a	NG 15b	NG 16	NG 17a	NG 17b	NG 18	NG 19a	NG 19b	NG 19c	NG 20a	NG 20b	NG 21a	NG 21b	UG 14	UG 15a	UG 15b	UG 16	UG 17	UG 18	UG 19	UG 20	UG 21	UG 22
	FPSERECPTR	Side effect experienced recently: partner feels during sex	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECPTR	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECPTR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECPTR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSERECDRY	Side effect experienced recently: vaginal dryness	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECDRY	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECDRY	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECDRY	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSERECWEAK	Side effect experienced recently: general weakness/pain	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECWEAK	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSERECWEAK	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERECWEAK	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
	FPSEBEADS	Method used when having side effects: beads	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEBEADS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEBEADS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEBEADS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEDIA	Method used when having side effects: diaphragm	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEDIA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEDIA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEDIA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEEC	Method used when having side effects: emergency	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEEC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEEC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEEC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEFC	Method used when having side effects: female condoms	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEFC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEFC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEFC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEFSTER	Method used when having side effects: female sterilization	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEFSTER	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEFSTER	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEFSTER	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEFJ	Method used when having side effects: foam/jelly	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEFJ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEFJ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEFJ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEIMP	Method used when having side effects: implants	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEIMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEIMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEIMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEINJ	Method used when having side effects: injectables	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEINJ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEINJ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEINJ	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEIUD	Method used when having side effects: IUD	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEIUD	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEIUD	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEIUD	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSELAM	Method used when having side effects: LAM	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSELAM	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSELAM	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSELAM	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEMC	Method used when having side effects: male condoms	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEMC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEMC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEMC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEMSTER	Method used when having side effects: male sterilization	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEMSTER	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEMSTER	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEMSTER	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEPILL	Method used when having side effects: pill	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPILL	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPILL	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPILL	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSERHY	Method used when having side effects: rhythm	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERHY	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERHY	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSERHY	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEWITH	Method used when having side effects: withdrawal	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEWITH	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEWITH	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEWITH	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.

Add to cart	Variable	Variable Label	Type	burkf 2014	burkf 2015	burkf 2016a	burkf 2016b	burkf 2017	burkf 2018	burkf 2020	burkf 2021	burkf 2022	condr 2013	condr 2014	condr 2015a	condr 2015b	condr 2015c	condr 2016a	condr 2016b	condr 2017a	condr 2017b	condr 2018a	condr 2018b	condr 2019a	condr 2019b	condr 2020	condr 2020	condr 2021	Variable	condr 2021	cotedi 2017	cotedi 2018	cotedi 2020	cotedi 2020b	cotedi 2021	cotedi 2022	ethio 2014a	ethio 2014b	ethio 2015	ethio 2016	ethio 2017	ethio 2018	ethio 2019	ethio 2020	ethio 2021	ghana 2013	ghana 2014a	ghana 2014b	ghana 2015	ghana 2016	ghana 2017	india 2016	india 2017a	india 2017b	Variable	india 2018	india 2020	india 2021	india 2022	indon 2015	indon 2016	kenya 2014a	kenya 2014b	kenya 2015a	kenya 2015b	kenya 2016	kenya 2017	kenya 2018	kenya 2019	kenya 2020	kenya 2021	niger 2015	niger 2016a	niger 2016b	niger 2017	niger 2018	niger 2020	niger 2022	niger 2023	nigera 2014a	Variable	nigera 2014b	nigera 2015a	nigera 2015b	nigera 2016	nigera 2017a	nigera 2017b	nigera 2018	nigera 2019a	nigera 2019b	nigera 2019c	nigera 2020a	nigera 2020b	nigera 2021a	nigera 2021b	ugand 2014	ugand 2015a	ugand 2015b	ugand 2016	ugand 2017	ugand 2018	ugand 2019	ugand 2020	ugand 2021	ugand 2022
Side Effects (heard) Variables (Group continued on next page...) [top]
Add to cart	Variable	Variable Label	Type	BF 14	BF 15	BF 16a	BF 16b	BF 17	BF 18	BF 20	BF 21	BF 22	CD 13	CD 14	CD 15a	CD 15b	CD 15c	CD 16a	CD 16b	CD 17a	CD 17b	CD 18a	CD 18b	CD 19a	CD 19b	CD 20	CD 20	CD 21	Variable	CD 21	CI 17	CI 18	CI 20	CI 20b	CI 21	CI 22	ET 14a	ET 14b	ET 15	ET 16	ET 17	ET 18	ET 19	ET 20	ET 21	GH 13	GH 14a	GH 14b	GH 15	GH 16	GH 17	IN 16	IN 17a	IN 17b	Variable	IN 18	IN 20	IN 21	IN 22	ID 15	ID 16	KE 14a	KE 14b	KE 15a	KE 15b	KE 16	KE 17	KE 18	KE 19	KE 20	KE 21	NE 15	NE 16a	NE 16b	NE 17	NE 18	NE 20	NE 22	NE 23	NG 14a	Variable	NG 14b	NG 15a	NG 15b	NG 16	NG 17a	NG 17b	NG 18	NG 19a	NG 19b	NG 19c	NG 20a	NG 20b	NG 21a	NG 21b	UG 14	UG 15a	UG 15b	UG 16	UG 17	UG 18	UG 19	UG 20	UG 21	UG 22
	FPSETALKCUR	Discussed side effects with anyone (current method)	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSETALKCUR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	FPSETALKCUR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSETALKCUR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.
	FPSETALKREC	Discussed side effects with anyone (most recent method)	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSETALKREC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSETALKREC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSETALKREC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.
	FPSESWITCH	Told if have side effects can switch FP	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSESWITCH	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	FPSESWITCH	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSESWITCH	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEPOSSIRREG	Possible side effect of FP method: irregular bleeding	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSIRREG	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSIRREG	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSIRREG	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEPOSSBLEEDLESS	Possible side effect of FP method: bleed less	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSBLEEDLESS	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSBLEEDLESS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSBLEEDLESS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEPOSSBLEEDMORE	Possible side effect of FP method: bleed more	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSBLEEDMORE	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSBLEEDMORE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSBLEEDMORE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEPOSSDIARR	Possible side effect of FP method: diarrhea	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSDIARR	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSDIARR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSDIARR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEPOSSFACE	Possible side effect of FP method: facial spotting	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSFACE	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSFACE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSFACE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEPOSSFERTDELAY	Possible side effect of FP method: delayed fertility	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSFERTDELAY	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSFERTDELAY	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSFERTDELAY	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEPOSSFPLOST	Possible side effect of FP method: fp lost	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSFPLOST	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSFPLOST	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSFPLOST	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEPOSSHEADACHE	Possible side effect of FP method: headache	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSHEADACHE	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSHEADACHE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSHEADACHE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEPOSSINFECT	Possible side effect of FP method: infection	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSINFECT	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSINFECT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSINFECT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEPOSSINFERT	Possible side effect of FP method: infertility	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSINFERT	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSINFERT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSINFERT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEPOSSLIBIDO	Possible side effect of FP method: lowered libido	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSLIBIDO	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSLIBIDO	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSLIBIDO	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEPOSSCRAMP	Possible side effect of FP method: more cramping	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSCRAMP	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSCRAMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSCRAMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEPOSSNAUSEA	Possible side effect of FP method: nausea	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSNAUSEA	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSNAUSEA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSNAUSEA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEPOSSSPOT	Possible side effect of FP method: spotting	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSSPOT	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSSPOT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSSPOT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEPOSSUTCRAMP	Possible side effect of FP method: uterine cramping	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSUTCRAMP	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSUTCRAMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSUTCRAMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEPOSSDRY	Possible side effect of FP method: vaginal dryness	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSDRY	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSDRY	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSDRY	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEPOSSWEAK	Possible side effect of FP method: weakness	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSWEAK	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSWEAK	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSWEAK	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
Add to cart	Variable	Variable Label	Type	burkf 2014	burkf 2015	burkf 2016a	burkf 2016b	burkf 2017	burkf 2018	burkf 2020	burkf 2021	burkf 2022	condr 2013	condr 2014	condr 2015a	condr 2015b	condr 2015c	condr 2016a	condr 2016b	condr 2017a	condr 2017b	condr 2018a	condr 2018b	condr 2019a	condr 2019b	condr 2020	condr 2020	condr 2021	Variable	condr 2021	cotedi 2017	cotedi 2018	cotedi 2020	cotedi 2020b	cotedi 2021	cotedi 2022	ethio 2014a	ethio 2014b	ethio 2015	ethio 2016	ethio 2017	ethio 2018	ethio 2019	ethio 2020	ethio 2021	ghana 2013	ghana 2014a	ghana 2014b	ghana 2015	ghana 2016	ghana 2017	india 2016	india 2017a	india 2017b	Variable	india 2018	india 2020	india 2021	india 2022	indon 2015	indon 2016	kenya 2014a	kenya 2014b	kenya 2015a	kenya 2015b	kenya 2016	kenya 2017	kenya 2018	kenya 2019	kenya 2020	kenya 2021	niger 2015	niger 2016a	niger 2016b	niger 2017	niger 2018	niger 2020	niger 2022	niger 2023	nigera 2014a	Variable	nigera 2014b	nigera 2015a	nigera 2015b	nigera 2016	nigera 2017a	nigera 2017b	nigera 2018	nigera 2019a	nigera 2019b	nigera 2019c	nigera 2020a	nigera 2020b	nigera 2021a	nigera 2021b	ugand 2014	ugand 2015a	ugand 2015b	ugand 2016	ugand 2017	ugand 2018	ugand 2019	ugand 2020	ugand 2021	ugand 2022
Add to cart	Variable	Variable Label	Type	BF 14	BF 15	BF 16a	BF 16b	BF 17	BF 18	BF 20	BF 21	BF 22	CD 13	CD 14	CD 15a	CD 15b	CD 15c	CD 16a	CD 16b	CD 17a	CD 17b	CD 18a	CD 18b	CD 19a	CD 19b	CD 20	CD 20	CD 21	Variable	CD 21	CI 17	CI 18	CI 20	CI 20b	CI 21	CI 22	ET 14a	ET 14b	ET 15	ET 16	ET 17	ET 18	ET 19	ET 20	ET 21	GH 13	GH 14a	GH 14b	GH 15	GH 16	GH 17	IN 16	IN 17a	IN 17b	Variable	IN 18	IN 20	IN 21	IN 22	ID 15	ID 16	KE 14a	KE 14b	KE 15a	KE 15b	KE 16	KE 17	KE 18	KE 19	KE 20	KE 21	NE 15	NE 16a	NE 16b	NE 17	NE 18	NE 20	NE 22	NE 23	NG 14a	Variable	NG 14b	NG 15a	NG 15b	NG 16	NG 17a	NG 17b	NG 18	NG 19a	NG 19b	NG 19c	NG 20a	NG 20b	NG 21a	NG 21b	UG 14	UG 15a	UG 15b	UG 16	UG 17	UG 18	UG 19	UG 20	UG 21	UG 22
	FPSEPOSSWTGAIN	Possible side effect of FP method: weight gain	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSWTGAIN	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSWTGAIN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSWTGAIN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.
	FPSEPOSSWTLOSS	Possible side effect of FP method: weight loss	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSWTLOSS	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSWTLOSS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FPSEPOSSWTLOSS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X	.	.	.	.

bf	Burkina Faso	burkf
cd	Congo (Democratic Republic)	condr
ci	Cote d'Ivoire	cotedi
et	Ethiopia	ethio
gh	Ghana	ghana
in	India	india
id	Indonesia	indon
ke	Kenya	kenya
ne	Niger	niger
ng	Nigeria	nigera
ug	Uganda	ugand

Data Cart

Your data extract

0	variables
0	samples